104 related articles for article (PubMed ID: 26412380)
1. ARF: connecting senescence and innate immunity for clearance.
Kearney AY; Anchang B; Plevritis S; Felsher DW
Aging (Albany NY); 2015 Sep; 7(9):613-5. PubMed ID: 26412380
[TBL] [Abstract][Full Text] [Related]
2. p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.
Yetil A; Anchang B; Gouw AM; Adam SJ; Zabuawala T; Parameswaran R; van Riggelen J; Plevritis S; Felsher DW
Oncotarget; 2015 Feb; 6(6):3563-77. PubMed ID: 25784651
[TBL] [Abstract][Full Text] [Related]
3. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
4. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar Arf sequesters Mdm2 and activates p53.
Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
[TBL] [Abstract][Full Text] [Related]
6. Anti-aging activity of the Ink4/Arf locus.
Matheu A; Maraver A; Collado M; Garcia-Cao I; Cañamero M; Borras C; Flores JM; Klatt P; Viña J; Serrano M
Aging Cell; 2009 Apr; 8(2):152-61. PubMed ID: 19239418
[TBL] [Abstract][Full Text] [Related]
7. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
[TBL] [Abstract][Full Text] [Related]
8. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation.
Wu CH; van Riggelen J; Yetil A; Fan AC; Bachireddy P; Felsher DW
Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13028-33. PubMed ID: 17664422
[TBL] [Abstract][Full Text] [Related]
9. Ink4a/Arf expression is a biomarker of aging.
Krishnamurthy J; Torrice C; Ramsey MR; Kovalev GI; Al-Regaiey K; Su L; Sharpless NE
J Clin Invest; 2004 Nov; 114(9):1299-307. PubMed ID: 15520862
[TBL] [Abstract][Full Text] [Related]
10. [Expression of P53, NPM1, Kras, c-Myc, p14(ARF) genes in blood cells of cancer patients before and after radiation therapy].
Shulenina LV; Ushenkova LN; Ledin EV; Shagirova ZhM; Raeva NF; Zasukhina GD; Mikhaĭlov VF
Radiats Biol Radioecol; 2012; 52(6):572-81. PubMed ID: 23516888
[TBL] [Abstract][Full Text] [Related]
11. Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium.
Chaum E; Winborn CS; Bhattacharya S
Mamm Genome; 2015 Jun; 26(5-6):210-21. PubMed ID: 25963977
[TBL] [Abstract][Full Text] [Related]
12. p16 and ARF: activation of teenage proteins in old age.
Satyanarayana A; Rudolph KL
J Clin Invest; 2004 Nov; 114(9):1237-40. PubMed ID: 15520854
[TBL] [Abstract][Full Text] [Related]
13. p53-induced apoptosis as a safeguard against cancer.
Asker C; Wiman KG; Selivanova G
Biochem Biophys Res Commun; 1999 Nov; 265(1):1-6. PubMed ID: 10548481
[TBL] [Abstract][Full Text] [Related]
14. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.
Xue W; Zender L; Miething C; Dickins RA; Hernando E; Krizhanovsky V; Cordon-Cardo C; Lowe SW
Nature; 2007 Feb; 445(7128):656-60. PubMed ID: 17251933
[TBL] [Abstract][Full Text] [Related]
15. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor.
Sreeramaneni R; Chaudhry A; McMahon M; Sherr CJ; Inoue K
Mol Cell Biol; 2005 Jan; 25(1):220-32. PubMed ID: 15601844
[TBL] [Abstract][Full Text] [Related]
16. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
Chen D; Shan J; Zhu WG; Qin J; Gu W
Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
[TBL] [Abstract][Full Text] [Related]
17. Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang Y; Xiong Y
Cell Growth Differ; 2001 Apr; 12(4):175-86. PubMed ID: 11331246
[TBL] [Abstract][Full Text] [Related]
18. ADP-ribosylation factors 1 and 6 regulate Wnt/β-catenin signaling via control of LRP6 phosphorylation.
Kim W; Kim SY; Kim T; Kim M; Bae DJ; Choi HI; Kim IS; Jho E
Oncogene; 2013 Jul; 32(28):3390-6. PubMed ID: 22907437
[TBL] [Abstract][Full Text] [Related]
19. The TRIP from ULF to ARF.
Collado M; Serrano M
Cancer Cell; 2010 Apr; 17(4):317-8. PubMed ID: 20385357
[TBL] [Abstract][Full Text] [Related]
20. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.
Giuriato S; Ryeom S; Fan AC; Bachireddy P; Lynch RC; Rioth MJ; van Riggelen J; Kopelman AM; Passegué E; Tang F; Folkman J; Felsher DW
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16266-71. PubMed ID: 17056717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
